Evidence map›Paper›PMID 40415308›Full record

ArticleBritish journal of haematology2025

Monoclonal immunoglobulin measurement by mass spectrometry in patients with multiple myeloma and kidney failure: Analysis from the EuLITE trial.

Graham McIlroy, Hannah V Giles, Amy Rollins, Gemma Malin, Libby Jones, Nicola J Wright, Oscar Berlanga, Simon North, Mark Cook, Colin Hutchison and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Graham McIlroyUniversity of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-4731-1784
Hannah V GilesUniversity of Birmingham, Birmingham, UK.
Amy RollinsThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Gemma MalinThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Libby JonesThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Nicola J WrightThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Oscar BerlangaThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Simon NorthThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Mark CookUniversity of Birmingham, Birmingham, UK.
Colin HutchisonHawke's Bay District Health Board, Hastings, New Zealand.
Nils HeyneUniversität Tübingen, Tübingen, Germany.
Katja WeiselUniversitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Jennifer PinneyUniversity Hospitals Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0001-8718-8066
Stephen HardingThe Binding Site (part of Thermo Fisher Scientific), Birmingham, UK.
Paul CockwellUniversity of Birmingham, Birmingham, UK.
Guy PrattUniversity of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0002-6937-2852

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

mass spectrometrymultiple myelomarenal medicine

Identifiers

PMID40415308
PMCPMC12234270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.